The future is calling: development & manufacturing of Janssen’s first CAR-T therapy
De opleiding Biomedische Laboratoriumtechnologie (BLT) van de Thomas More Hogeschool organiseert op donderdag 30 maart een gratis avondlezing.
“The future is calling: development & manufacturing of Janssen’s first CAR-T therapy”
During this session we will address the unmet needs of patients living with cancer as we will explore specifically Janssen’s novel therapeutic strategy on CAR-T therapy.
Janssen will produce innovative cell therapies in Belgium for the treatment of certain types of cancer in Europe. Together with Legend Biotech, we are building our first state-of-the-art facilities both in Ghent and Beerse to make the manufacturing of CAR-T cell therapy possible.
Find out more about this innovative journey, the hope it brings for so many patients and the unique opportunities that are created for talent with a passion for biotechnology.
Wie?
Sprekers: Bie Van de Vloet en An-Sofie Stevens – Janssen Pharmaceutica
Wanneer en waar?
De lezing vindt plaats op 30/03/2023 tussen 19.00 en 20u30 bij Thomas More, Kleinhoefstraat 4 in Geel.
De lezing is gratis maar vooraf inschrijven is noodzakelijk en kan via onderstaande link:
https://forms.office.com/e/XbdTMyDyrh